Investment-Ready Through Rigorous Valuation and Due Diligence

One of our core services involves conducting detailed company valuations and techno-economic assessments to inform equity negotiations, structure funding rounds, and secure investor buy-in. These valuations incorporate:

• Forecasted market potential and competitive dynamics;

• R&D pipeline viability and cost of scale-up;

• Capital infrastructure requirements;

• And robust financial modelling, including IRR, NPV, and ROI scenarios.

For example, Maravion has supported companies in raising investment rounds ranging from R10 million to over US$10 million, enabling product development, GMP scale-up studies, and early commercialisation efforts. While the identities of these companies remain confidential under NDA, each engagement reflects our deep understanding of biotech business models and the funding landscape.

Supporting Public Sector Partners and Funders

Beyond private sector engagements, Maravion, through its founder has conducted numerous commercial and technical due diligence exercises for national funding agencies, including the assessment of technology development proposals and company valuations. These reviews are essential for de-risking public investment in biotech and ensuring alignment with national innovation priorities.

Our commercial due diligence process examines:

• IP position and freedom-to-operate;

• Business model viability;

• Regulatory pathway feasibility;

• And potential for strategic partnerships and market access.

From Strategy to Scale

Ultimately, Maravion’s goal is to help biotech ventures build credible, investable stories. Our work enables founders to engage with funders and investors confidently, backed by a clear understanding of their value proposition, growth potential, and capital needs.

Whether you're a start-up preparing your first investment round or a more established player scaling into new markets, we are ready to help you design a funding strategy that works, one that supports science with substance, scale, and sustainability.

Rigorous Valuation and Due Diligence